• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多效蛋白在肿瘤生长和血管生成中的作用。

Roles of pleiotrophin in tumor growth and angiogenesis.

机构信息

Laboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras, Greece.

出版信息

Eur Cytokine Netw. 2009 Dec;20(4):180-90. doi: 10.1684/ecn.2009.0172.

DOI:10.1684/ecn.2009.0172
PMID:20167557
Abstract

Pleiotrophin (PTN) is a heparin-binding growth factor with diverse biological activities, the most studied of these being those related to the nervous system, tumor growth and angiogenesis. Although interest in the involvement of PTN in tumor growth is increasing, many questions remain unanswered, particularly concerning the receptors and the signaling pathways involved. In this review, we briefly introduce PTN, and summarize data on its involvement in tumor growth and angiogenesis, and on what is known to date concerning the receptors and pathways involved.

摘要

多效蛋白(PTN)是一种肝素结合生长因子,具有多种生物学活性,其中研究最多的是与神经系统、肿瘤生长和血管生成相关的活性。尽管人们对 PTN 参与肿瘤生长的兴趣日益增加,但仍有许多问题尚未得到解答,特别是涉及到相关的受体和信号通路。在这篇综述中,我们简要介绍了 PTN,并总结了其在肿瘤生长和血管生成中的作用,以及目前已知的涉及的受体和信号通路的相关数据。

相似文献

1
Roles of pleiotrophin in tumor growth and angiogenesis.多效蛋白在肿瘤生长和血管生成中的作用。
Eur Cytokine Netw. 2009 Dec;20(4):180-90. doi: 10.1684/ecn.2009.0172.
2
Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch.在多效生长因子中鉴定血管生成信号域,揭示了血管生成开关的一种机制。
Biochem Biophys Res Commun. 2006 May 5;343(2):653-8. doi: 10.1016/j.bbrc.2006.03.006. Epub 2006 Mar 10.
3
Heparin-binding protein pleiotrophin: an important player in the angiogenic process.肝素结合蛋白多效生长因子:血管生成过程中的重要参与者。
Connect Tissue Res. 2008;49(3):149-52. doi: 10.1080/03008200802148652.
4
Expression of pleiotrophin and its receptors in human placenta suggests roles in trophoblast life cycle and angiogenesis.多效生长因子及其受体在人胎盘中的表达表明其在滋养层细胞生命周期和血管生成中发挥作用。
Placenta. 2009 Jul;30(7):649-53. doi: 10.1016/j.placenta.2009.05.001. Epub 2009 May 28.
5
Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway.多效生长因子:一种具有多种功能和新型信号通路的细胞因子。
Arch Biochem Biophys. 2002 Jan 15;397(2):162-71. doi: 10.1006/abbi.2001.2705.
6
Pleiotrophin, a multifunctional angiogenic factor: mechanisms and pathways in normal and pathological angiogenesis.多效生长因子,一种多功能血管生成因子:正常及病理性血管生成中的机制与途径
Curr Opin Hematol. 2008 May;15(3):210-4. doi: 10.1097/MOH.0b013e3282fdc69e.
7
Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cells.肝素亲和调节肽/多效生长因子对C6胶质瘤细胞的多种生物学活性产生负面影响。
Eur J Cell Biol. 2008 Jan;87(1):17-29. doi: 10.1016/j.ejcb.2007.07.007. Epub 2007 Sep 18.
8
Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain.一种与其C-血小板反应蛋白重复序列-I结构域相对应的合成肽对多效生长因子的促有丝分裂、促血管生成和致瘤活性的抑制作用。
J Cell Physiol. 2008 Jan;214(1):250-9. doi: 10.1002/jcp.21191.
9
Pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta as regulators of angiogenesis and cancer.多效生长因子及其受体蛋白酪氨酸磷酸酶β/ζ作为血管生成和癌症的调节因子。
Biochim Biophys Acta. 2016 Dec;1866(2):252-265. doi: 10.1016/j.bbcan.2016.09.007. Epub 2016 Sep 29.
10
Serum stimulates Pleiotrophin gene expression in an AP-1-dependent manner in human endothelial and glioblastoma cells.血清以AP-1依赖的方式刺激人内皮细胞和成胶质细胞瘤细胞中的多效生长因子基因表达。
Anticancer Res. 2009 Jan;29(1):349-54.

引用本文的文献

1
Modulation of fenestrated vasculature in the median eminence and area postrema in response to neurotoxin exposure and its impairment in aging.正中隆起和最后区有孔脉管系统对神经毒素暴露的反应调节及其在衰老过程中的损伤。
Front Aging Neurosci. 2025 Aug 19;17:1634283. doi: 10.3389/fnagi.2025.1634283. eCollection 2025.
2
Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment.血浆蛋白质组学生物标志物可预测晚期胆管癌患者接受卡瑞利珠单抗联合GEMOX治疗时的治疗反应。
NPJ Precis Oncol. 2025 Apr 7;9(1):102. doi: 10.1038/s41698-025-00879-9.
3
LcProt: Proteomics-based identification of plasma biomarkers for lung cancer multievent, a multicentre study.
LcProt:基于蛋白质组学的肺癌多事件血浆生物标志物鉴定,一项多中心研究。
Clin Transl Med. 2025 Jan;15(1):e70160. doi: 10.1002/ctm2.70160.
4
Comprehensive Proteomics Profiling Identifies Circulating Biomarkers to Distinguish Hypertrophic Cardiomyopathy From Other Cardiomyopathies With Left Ventricular Hypertrophy.综合蛋白质组学分析鉴定循环生物标志物以区分肥厚型心肌病与其他伴有左心室肥厚的心肌病。
Circ Heart Fail. 2025 Jan;18(1):e012434. doi: 10.1161/CIRCHEARTFAILURE.124.012434. Epub 2024 Nov 11.
5
Pleiotrophin-Loaded Mesoporous Silica Nanoparticles as a Possible Treatment for Osteoporosis.载有促生长蛋白的介孔二氧化硅纳米颗粒作为骨质疏松症的一种可能治疗方法
Pharmaceutics. 2023 Feb 16;15(2):658. doi: 10.3390/pharmaceutics15020658.
6
Identification and characterization of four immune-related signatures in keloid.鉴定和分析瘢痕疙瘩中四个与免疫相关的特征。
Front Immunol. 2022 Jul 27;13:942446. doi: 10.3389/fimmu.2022.942446. eCollection 2022.
7
Pleiotrophin Expression and Actions in Pancreatic β-Cells.pleiotrophin 在胰腺β细胞中的表达和作用。
Front Endocrinol (Lausanne). 2022 Feb 18;13:777868. doi: 10.3389/fendo.2022.777868. eCollection 2022.
8
Genome-wide screening identifies oncofetal lncRNA Ptn-dt promoting the proliferation of hepatocellular carcinoma cells by regulating the Ptn receptor.全基因组筛选鉴定出癌胚 lncRNA Ptn-dt 通过调节 Ptn 受体促进肝癌细胞的增殖。
Oncogene. 2019 May;38(18):3428-3445. doi: 10.1038/s41388-018-0643-z. Epub 2019 Jan 14.
9
A meta-analysis on the role of pleiotrophin (PTN) as a prognostic factor in cancer.一项关于多效生长因子(PTN)作为癌症预后因素的作用的荟萃分析。
PLoS One. 2018 Nov 14;13(11):e0207473. doi: 10.1371/journal.pone.0207473. eCollection 2018.
10
Pleiotrophin deletion alters glucose homeostasis, energy metabolism and brown fat thermogenic function in mice.pleiotrophin 缺失改变小鼠的葡萄糖稳态、能量代谢和棕色脂肪产热功能。
Diabetologia. 2019 Jan;62(1):123-135. doi: 10.1007/s00125-018-4746-4. Epub 2018 Oct 16.